Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stock buyback
Pharma
Pfizer pawns off final stake in OTC outfit Haleon for £2.5B
With Pfizer’s final stake sale in the bag, the big pharma duo behind Haleon has formally parted ways with the standalone consumer health giant.
Fraiser Kansteiner
Mar 19, 2025 10:22am
High-flying Eli Lilly plots $15B share buyback campaign
Dec 10, 2024 11:31am
Pfizer offloads another tranche of Haleon shares for £2.4B
Oct 1, 2024 10:23am
J&J aims to offload 80% of its Kenvue stake via exchange offer
Jul 24, 2023 10:44am
Novartis to buy back $15B in shares despite Entresto setback
Jul 18, 2023 11:05am
Amid share price woes, Novartis readies $11B buyback program
Mar 13, 2023 2:14pm
